Speaker: Shawn Fernando

Shawn Fernando, Senior Researcher, Bioanalytical Development, Morphotek, Exton, PA, USA, presented Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Trials at the North American Gyrolab Seminar, USA.

In this webinar, the researchers looked to increase the throughput of the PK assay of investigational IgG1 antibody therapeutic for a clinical study using Gyrolab platform. 

In more than 450 runs performed, the Gyrolab PK assay showed:

  • High pass rate of 94%
  • High consistency and accuracy of QC standards and samples, across reagent lots and with different operators
  • Throughput of 16,000 sample results in 6 months

You can read more about this application here.